Histologic transformation of follicular lymphoma to diffuse lymphoma represents tumor progression by a single malignant B cell by unknown
Histologic Transformation of Follicular Lymphoma to
Diffuse Lymphoma Represents Tumor Progression by
a Single Malignant B Cell
By Andrew D. Zelenetz, Thomas T. Chen, and Ronald Levy
From the Division of Oncology, Department ofMedicine, Stanford Medical School, Stanford,
California 94305
Summary
To investigate the clonal relationship between follicular lymphoma (FL) and transformed diffuse
lymphoma (tDL), we examined the expression of tumor idiotype, immunoglobulin (Ig) gene
rearrangements and sequence of Ig variable genesin paired tissue specimens. All 16 cases analyzed
expressed surface immunoglobulin (slg) on both the FL and the OL, though the immunophenotype
of one case of FL could not be definitively determined. In 14 of 15 cases, the surface immuno-
phenotype was preserved; the exception was likely secondary to a class switch from IgM to IgG.
In 12 of 13 cases, antiidiotypic monoclonal antibodies prepared against the FL reacted with the
paired tDL. Analysis of Ig gene rearrangements in four cases by Southern blot hybridization
showed evidence of clonal relationships in all cases though concordance was not seen with all
probes tested (Ctc, CX, J., PFL1, and PFL2). In the one case that had a discordant L chain
rearrangement, sequence analysis of the L chain demonstrated a common mature B cell origin
for both the FL and tDL. To determine whether tDL arose from one or more FL cells, the
sequences of the H chain variable genes were analyzed. Individual clones of the V region gene
of the FL showed a random distribution ofchanges throughout the sequence. In contrast, individual
clones of the V region gene from tDL shared numerous nonrandom sequence alterations, implying
a common single cell origin. In conclusion, tDL is a mature B cell and arises by transformation
of a single FL cell.
F
ollicular low-grade non-Hodgkin's lymphoma (FL)' has
a relatively indolent course with the median survival of
8-10 yr (1, 2) . However, histologic conversion to a more ag-
gressive diffuse lymphoma (DL) is frequently observed at re-
lapse or progression and portends a very poor survival (3,
4) . The actuarial risk of histologic conversion is 44% at 5
yr and 67% at 10 yr (2). Histologic conversion is not mono-
morphic, a variety ofintermediate and high grade tumor histol-
ogies have been observed. (In this study, lymphomas will be
classified according to the Working Formulation; reference
1.) Antemortem studies suggest that the most common con-
version is to diffuse large cell lymphoma (DLCL) (3, 4) though
small noncleaved lymphoma (Burkitt's [SNC-B] and non-
Burkitt's [SNC-nB]) (4-6) and acute lymphoblastic leukemia
(ALL) have been observed (7-9). A postmortem study (10)
of 56 patients initially diagnosed with FL found that the final
Abbreviations used in this paper. ALL, acute lymphoblastic leukemia; DL,
diffuse lymphoma; DLCL, diffuselargecelllymphoma; DML, diffusemixed
lymphoma; FL, follicular lymphoma; FLCL, follicular large cell lymphoma;
FML, follicular mixed lymphoma; FSCL, follicular small-cleaved cell
lymphoma; LL, lymphoblastic lymphoma; MBR, major breakpoint cluster
region; SNC-B, small noncleaved Burkitt's lymphoma; SNC-nB, small
noncleaved, non-Burkitt's lymphoma; slg, surface immunoglobulin; tDL,
transformed diffuse lymphoma; TdT, terminal deoxynucleotidyltransferase.
diagnosis was diffuse mixed lymphoma (DML) or DLCL in
41% of the casesand SNC-nB in 20%. No caseswere classified
as Burkitt's or lymphoblastic lymphoma/leukemia. Given
these diverse outcomes it is ofinterest to investigate whether
they represent tumor progression of the original FL or a de
novo malignant lymphoma as others have done with diver-
gent conclusions (5, 7-9, 11, 12).
We have now reexamined the relationship between FL and
histologically transformed lymphoma by a combination of
approaches. Using antiidiotypic mAbs we find that the sur-
face immunoglobulin (sIg) expressed by the transformed diffuse
lymphoma (tDL) to be the same as the antecedent FL in 12
of 13 cases. Southern hybridization analysis in four cases (three
cases in which antiidiotypic antibodies were not available,
and one case in which the tDL failed to bind an antiidiotypic
antibody reactive with the FL) demonstrated evidence for a
clonal relationship between the FL and tDL. To further prove
the clonal relationship we performed nucleotide sequencing
of the L and H chain V region genes expressed by the two
forms of tumor in one patient . The results prove a common
cell of origin for both tumors within a given patient and
suggest that tDL arises as a subclone of a single mature B
cell member of the FL tumor.
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TumorMaterial and Cell Lines.
￿
Patients with FL were biopsied
for preparation of antiidiotypic antibodies. Tumor material was
stored as either single cell suspension or tissueblocks as previously
described (13). Subsequent biopsies were obtained at various in-
tervals when there was a clinical suspicion of histologic conver-
sion. We establishedcell linesfrom thetDLforcaseJP by themethod
of Tweeddale et al. (14) Numerous colonies of cells grew initially
in methylcellulose. Colonies from independent plates were trans-
ferred to IMDM supplemented with 20% FCS, 5 x 10 -s M
2-ME and adaptedto liquid culture. Three independent cell lines-
JP-DLCIrl, JP-DLCL,3, andJP-DLCh4-were thus derived. Fur-
ther characterization by flow cytometry demonstrated they allex-
pressed a h/A sIg as did the initial FL.
Aniidiotypic Antibodies. Antiidiotypic mAbs were prepared
by the method of rescue fusion from FL tumors as previously de-
scribed (15).
Immunohistochemistry.
￿
Frozen sections ofbiopsy material were
stained as previously described (16) usingbiotinylated goat anti-
mouse Ig followed by horseradish peroxidase-coupled avidin.
Flow Cytometry.
￿
Single cell suspensions of tissue specimenswere
stained with monoclonal or polyclonal antibodies either directly
or indirectly and analyzed on the fluorescence-activated cell sorter
(FRCS440; Becton Dickinson& Company, Mountain View, CA)
as previously described(17). Theantibodies used fordirect staining
included Len 4-FITC (Becton Dickinson & Co.); goat F(ab')2
anti-human K-FITC, goat F(ab')z anti-human A-FITC, goat
F(ab')Z anti-human IgG-FITC, and goat F(ab')a anti-human IgM-
FITC (TagoInc., Burlingame, CA). Cellswere stainedwith specific
or class-matched irrelevant antiidiotypic mouse mAbs in a two-
step assay with a goat F(ab')2 anti-mouse Ig-FITC second step
(Tago Inc.).
Cellular DNA andRNA Isolation.
￿
Totalcellular RNAwaspre-
pared by the guanidinium isothiocyanate/CsCl method (18) and
poly(A)' RNA was selected on oligo-dTcellulose spin columns
(Pharmacia Fine Chemicals, Piscataway, NJ) as recommended by
the manufacturer. GenomicDNAwas isolated from theCsCl gra-
dient as follows: the upper layer of the step gradient was trans-
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ferred to a 15-mlconical bottom tube; 2 volof room temperature
ethanol were layered onto the DNA solution; and the DNA was
spooledonto aglassrod. DNAwasfurther purified by incubation
with proteinase K (50,ug/ml) followed by three extractions with
phenol/chloroform (1:1) and oneextraction with chloroform. DNA
was recoveredby ethanolprecipitationaftertheaddition ofsodium
acetate to 0.1 M.
Southern HybridizationAnalyses.
￿
DNA transfer to a positively
charged nylon membrane (OptiBlot, IBI, New Haven, CT) was
performed by vacuum blotting as recommendedby the manufac-
turer (LKB Instruments Inc., Bromma, Sweden) with the excep-
tion that the transfer solution was 1x SSC. Probes for Ig gene
rearrangements were prepared from JH (19), Crc (20, 21), CX 2.5,
and CA 3.5 (22). Additional probes were prepared for the major
andminorbreakpoint cluster regions characteristic of the t(14; 18)
in FL, PFLI (23), and PFL2 (24). DNA was labeled with [a-11P1
dCTP byrandom hexamerpriming(25). Hybridization andwashing
conditions were as recommendedby the membrane manufacturer.
Oligonucleotides.
￿
Defined oligonucleotides were prepared in a
DNAsynthesizer (model 380 B; AppliedBiosystems, Foster City,
CA) andpurified by HPLC chromatography. Oligonucleotides T3
andT7 were obtained from Strategene (LaJolla, CA). The oligo-
nucleotides used in this study are listed in Table 1.
Preparation ofSfiLA andSfiLB Adaptors.
￿
TheSfil.A (orSfil.B)
adaptor was formed by annealing equimolar quantities of phos-
phorylated oligionucleotides Sfi/A.I (orSfi/B.I) andSfi/Cas previ-
ously described (26) .
cDNA Cloning ofX Variable Genes.
￿
Directional cDNA libraries
were prepared from the FL and DL of casesJP and MT as previ-
ously described (26). Libraries were screened at high density (27)
using a CX probe. Candidate clones were picked and rescreened
at lower density until a single isolate was obtained.
PCR Amplification andCloningofHChain Variable Genes.
￿
PCR
was performedin a DNA thermal cycler as recommended by the
supplier (Perkin-Elmer Corp., Norwalk, CT) with minor modi-
fication. Primer concentration was reduced to 0.5 pM andcycling
was as follows: first cycle of 2 min at 94°C (denaturation), 30 s
at 55°C (annealing), 30 s at 72°C (extension); 35 cycles with the
denaturation time reduced to 15 s; and a 5-min final extension at
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Table 1. Oligonucleotides Used in this Study
Designation Sequence
V1-L 5'-CCATGGACTGGACCTGGAGG
V2-L 5'-ATGGACATACTTTGTTCCAC
V3-L 5'-CCATGGAGTTTGGGCTGAGC
V4-L 5'-ATGAAACACCTGTGGTTCTT
V.5-L 5'-ATGGGGTCAACCGCCATCCT
V6-L 5'-ATGTCTGTCTCCTTCCTCAT
JxSfiB 5'-GTGGCCACAGTGGCCACCTGAGGAGACGGTGACCAGGGT
CIA17 5'-CAGGAGACGAGGGGGAA
Sfi/C 5'-TGGCCATGG
Sfi/A.I 5'-CCATGGCCAGCA
Sfi/B.I 5'-CCATGGCCACTG
HX8 5'-CGGGTAGAAGTCACT
T3 5'-ATTAACCCTCACTAAAG
T7 5'-AATACGACTCACTATAG72°C. Initial templates were either 1 Ag of genomic DNA or first-
strand cDNA prepared from 0.5-3 gg of poly(A)* RNA (28). For
sequencing ofPCR products, asymmetric amplifications were per-
formed with primer concentrations of0.5 and 0.01 uM using gel-
purified primary amplification products as template. PCR prod-
ucts to be cloned were extracted with 3 vol ofchloroform followed
by phenol/chloroform (1:1) and chloroform extractions. The DNA
was then precipitated after the addition of0.1 vol of3 M Na ace-
tate, pH 5.5, 20 hg glycogen (Boeringer Mannheim Biochemicals,
Indianapolis, ID) and 2.5 vol of ethanol. DNA was resuspended
in double-distilled H2O and ligated to 100 pmol of SfiI.A adaptor
(or 100 pmol of both SfiI.A and SfiI.B adaptors) in 0.5x KGB
(Ix = 100 mM potassium glutamate, 25 mM Tris acetate, pH
7.6, 20 mM magnesium acetate, 100 mg/ml BSA,1 mM 2-ME) (29)
buffer supplemented with 1 mM ATP and 2,000 U T4 DNA ligase
(New England Biolabs, Beverly, MA) in a final reaction of 10,ul
and incubated at 15°C for 12-16 h followed by heat inactivation
of the DNA ligase at 70°C for 10 min. (When the JH SfiB primer
adaptor was used as the 3' amplimer, the reaction was adjusted to
100 F.l of 0.5 x KGB buffer and digested with 100 U Sfil and in-
cubated for 90 min at 50°C.) The band of interest was resolved
on a 3% NuSieve GTG-agarose gel (FMC Bioproducts, Rockland,
ME) and cut out with a sterile scalpel blade. The gel slice was melted
at 65°C and 1-2 /A of the gel combined with 10 ng of pLIB:AZ
or pLIB:ZA (26) and ligated for 2-16 h at 15°C. The ligation reac-
tion was diluted to 100 j.1, extracted, and precipitated as above.
The ligated DNA was washed three times with 70% ethanol to
remove residual salt. The DNA was resuspended in 10 F,l double-
distilled H2O and 1 P,1 was used to electrotransform (30) E. coli
XL1-Blue (Stratagene).
Plasmid Isolation. Plasmid DNA was prepared on Qiagen
(Qiagen, Studio City, CA) exchange resin as recommended by the
manufacturer.
Sequencing.
￿
Double-stranded plasmid DNA was sequenced (31)
after denaturation of the template with 0.4 N NaOH for 10 min
at room temperature followed by neutralization with 1 vol of0.9 M
Na acetate, pH 5.5, and ethanol precipitation. Template was an-
nealed with 0.5 pmol of sequencing primer at 37°C for 30 min.
Primers were removed from asymmetric PCR templates by chro-
matographyon an exchange resin (Qiagen) using the protocol for
M13 DNA recommended by the manufacturer. Asymmetric PCR
templates were annealed with 1 pmol of the primer that was lim-
itingin the PCR reaction and sequenced. Sequences were analyzed
with the assistance of the University of Wisconsin Genetic Com-
puter Group programs (32) installed at the VAX computer facility
in the Department of Cell Biology at Stanford University (Stan-
ford, CA).
Results
FL 1diotype Is Expressed on TransformedLymphoma.
￿
To in-
vestigate the relationship between FL and tDL we examined
the immunophenotype of serial specimens from 16 cases of
histologic conversion by immunohistochemistry and/or flow
cytometry. The results, shown in Table 2, demonstrate that
there was concordance of immunophenotype in 14 of 15 cases
in which it could be determined. The exception, case FB,
expressed an IgM K on the FL and an IgG K on the tDL
and is likely explained by an H chain class switch. The FL
of case BH demonstrated high back-ground staining with
L chain-specific antibody reagent; hence, an L chain deter-
mination could not be made in that case.
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The immunophenotype is only a rough measure of relat-
edness between the tumor types. However, antibodies directed
against idiotypic determinants of the sIg provide a highly
specific marker for B cell lymphoma (15). In 13 of 16 cases,
one or more antiidiotypic mAbs were available that had been
prepared against the idiotype rescued from the FL (13). In
12 of 13 cases, the tDL was also reactive with the antiidio-
typic mAb reagents. Even in case BH, in which the FL L
chain type could not be determined, the antiidiotype was found
to react with both the FL and tDL. In cases BE and RT,
multiple tissue specimens showed a spectrum of histologies
from FSCL progressing to FLC and finally to DLCL; all the
samples expressed the tumor idiotype. Case EC was the sole
instance ofa transformed lymphoma failing to react with the
antiiodiotypic reagent. In three cases-JP, MT, and FB-
antiidiotypic mAbs were unavailable.
GeneRearrangements Suggest Common Clonal Origins ofFL
and tDL. The analysis of Ig gene rearrangements can be used
as a marker for monoclonal B cell proliferation (33). If mul-
tiple tumor isolates demonstrate identical rearrangements, then
they may be suspected to have derived from a common pro-
genitor. The results of Southern blot analyses are shown in
Fig. 1 for cases ofJP, MT, FB, and EC. DNA was prepared
from the FL and tDL tissue samples listed in Table 2 with
the exception of case JP tDL where the tDL cell lines were
used (see Materials and Methods). In case MT there was con-
cordance of the rearranged L chain band detected with the
X constant region probe between EcoRl-digested DNA ex-
tracted from FL and tDL (Fig. 1 A, lanes S and 6). When
the same samples were digested with HindIIl and hybridized
with a JH probe, two rearrangements were seen in both the
FL and tDL; however, only the 5.5-kb band was concordant
(Fig. 1 B, lanes 5 and 6) . In the FL, a second rearrangement
was seen at 6 kb in addition to a germline fragment of 12
kb. The germline band arises from normal cells that frequently
infiltrate these tumor specimens (33). In the tDL, the second
rearrangement was 8 kb and only a traceamount of the germ-
line DNA is seen. Since MT produces a sIg, one of the J,,
rearrangements must be productive; furthermore in FL, the
second J,, rearrangement is often involved in the t(14;18)
chromosomal translocation in which the JH segment is jux-
taposed to the bcl-2 protooncogene (23). To determine if one
of the JH rearrangements was involved in the t(14;18), the
HindlII blot was rehybridized with a chromosome 18 probe,
PFLI, for the major breakpointcluster region (MBR) of the
t(14;18) (23). This demonstrated a concordant 5.5-kb band
(Fig. 1 C, lanes 5 and 6) at exactly the same position as was
observed with the J,, probe (Fig. 1 B, lanes 5 and,6). Hence,
the 5.5-kb band observed with theJx and MBR probes must
be derived from the t(14; 18); whereas, the nonidentical rear-
rangement detected with the J. probe in the MT FL and
tDL specimens must be the productive allele.
In case JP, a single rearrangement of the X constant (CA)
couldbe detected in the FL at 6.2 kb (Fig. 1 A, lane 1). The
prominent germline bands in this sample indicates substan-
tial infiltration of the tumor by cells without clonal rearrange-
ments; nonetheless, a prolonged exposure failed to reveal a
second rearrangement (data not shown). The three cell lines" Site of tissue biopsy. l, left; r, right. LN sites: axil, axillary; cerv, cervial; fern, femoral; ing, inguinal; pao, paraarotic; scln, superclavicular; LN
sns, lymph node, site not specified. Chest, breast, and gluteal are soft tissue extranodal sites.
t Surgical pathologic diagnosis according to the Working Formulation (reference 1).
S Reactivity of antiidiotypic mAb on tissue or by flow cytometry. When analysis by flow cytometry the percent of tumor cells staining is shown
in parentheses. % Tumor cells = % staining with correct L chain - % staining with incorrect L chain.
II N/A, Antiidiotypic mAb not available.
derived from the tDL had two rearrangements detectable at
3.8 and 8.6 kb; they were concordant among the three cell
lines though distinct from the FL. Analysis of the H chain
locus with the JH probe revealed the FL and tDL cell lines
to be concordant for two rearranged bands at 2.7 and 9.0
kb (Fig. 1 B, lanes 1-4) . Rehybridization of this blot with
probes for the t(14;18) MBR (PFL1, Fig. 1 C, lanes 1-4)
or the minor cluster region (PFL2; data not shown) failed
to show evidence of achromosomaltranslocation in this tumor.
In case FB, analysis of the BamHI-digested DNA with a
probe for the rc constant (Crc) region revealed a concordant
band >15 kb between the FL and tDL (Fig. 1 D, lanes 7
and 8). Both the H chain alleles were rearranged in the FL
and tDL though only the 7.2-kb band was concordant (Fig.
1 E, lanes 7 and 8). Again, a germline band was detected
because of infiltration of the specimen with nontumor cells.
In the FL sample J crosshybridizing bands could be seen at
3.8 and 4.5 kb as previously described (33). Analysis with
the PFL1 probe (Fig. 1 F, lanes 7and 8) and the PFL2 probe
(datanot shown) didnot demonstrate rearrangements; there-
fore, assignment of the productive JH allele could not be done.
Finally, the analysis of case EC of BamHI-digested DNA
with the Crc probe revealed a concordant rearrangement of
7.9 kb between the FL and tDL (Fig. 1 D, lanes 9 and 10).
FL DNA digested with HindIII and probed with J demon-
strated two bands of 3.8 and 4.6 kb (Fig. 1 E, lanes 9 and
10). Similar analysis of the tDL demonstrated a 6.1-kb band
in addition to thebands seen in the FL. In the tDL, the 3.8-
kb band is decreased in intensity relative to the new 6.1-kb
band. Since the tDL tumor sample was an admixture of fol-
licular and diffuse large cell lymphoma, it is possible that
the faint 3.8-kb band is arising from the residual follicular
DNA. Reprobing of this blot with the PFL1 probe (Fig. 1
F, lanes 9 and 10) and the PFL2 probe (data not shown) re-
vealed only the germline configuration.
Sequence of the L Chain Proves a Common B Cell Origin of
FL and tDL. The Southern hybridization analysis of the L
chainrearrangement(s) of the FL and tDL in case JP demon-
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Table 2. Surface Immunoglobulin and Antiidiotypic mAb Reactivity of Paired FL and tDL
Case Date Site` Diagnosis# slg ID (%)S Case Date Site Diagnosis slg ID (%)
BH 5/24/84 1-cerv FML A + JP 8/31/88 1-cerv FML AX N/A
11/4/88 r-axil DML AX + (92) 1/27/89 PBL DLCL AX N/A
BL 1/27/84 spleen FSCL Arc + (100) LV 10/15/86 1-ing FML Arc + (53)
10/6/87 breast DLCL Arc + 10/27/88 1-ing F/DLCL Arc + (97)
CL 8/23/88 1-axil FSCL Arc + MW 9/19/81 1-cerv FML AX +
6/13/89 1-scln SNC,nB Arc + (100) 10/31/83 r-ing DML AX +
FB 6/2/83 r-axil FSCL Arc N/All RF 11/6/86 r-iliac FML Arc + (100)
12/13/84 r-ing IBL yrc N/A 10/11/88 pao DL Arc +
JC 10/6/83 spleen FSCL -yX + (92) RS 1/19/88 1-ing FSCL cxX + (100)
10/9/86 skin DLCL -yX + 6/24/88 r-ing DLCL ceX + (88)
BE 9/21/84 r-axil FSCL Arc + (92) RT 11/15/85 1-fern FSCL AX + (100)
6/4/87 LN sns FLCL Arc + 11/22/88 r-ing FLC AX + (100)
4/14/88 r-cerv F/DLCL Arc + (94) 1/5/90 chest DLCL AA + (92)
EC 3/26/87 1-cerv FSCL Arc + (100) RW 3/27/84 r-ing FML yA + (100)
4/6/89 r-axil F/DLCL Arc - 1/8/87 1-cerv DML -yX + (95)
8/23/89 1-ing F/DLCL Arc - 6/21/88 r-cerv DML 'yX +
MT 5/7/87 r-axil FSCL AX N/A SG 11/18/86 spleen FSCL yrc + (82)
12/29/88 gluteal DLCL AA N/A 4/28/88 1-ing DML -yrc + (100)
1/18/89 PBL DLCL AX N/A 10/7/88 1-scln FML -yrc +Figure 1 .
￿
Analysis of Ig gene rearrangements and t(14;18) translocation by Southern blot analysis . DNA was isolated from paired FL and tDL speci-
mens and designated as follows : (lanes 1) JP FL [8/31/881; (lanes 2) JP-DLCL1; .(lanes 3) JP-CLCIT3; (lanes 4) JP-DLCL4 ; (lanes 5) MT FL [5/7/871 ;
(lanes 6) MT DL [1/18/891; (lanes 7) FB FL [6/2/83) ; (lanes 8) FB DL [12/13/84); (lanes 9) EC FL [3/26/871 ; and (lanes 10) EC DL [4/6/891 .
DNA was digested with EcoRI and probed with C;, (A), HindIII and probed with JN (B and E) or BamHI and probed with C (D) . Filters from
B andE were stripped of probe and rehybridized with either a PFLI (C and F) or PFL2 probe (not shown) . The migration of germline (solid arrow)
and rearranged (open arrow) DNA as well as molecular weight markers are indicated .
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Zelenetz et al .strated bands of different sizes. Since the H chain rearrange-
ments were identical in the FL and tDL, this result could
be explained if the FL and tDL lymphomas had arisen from
a common pre-B cell clone subsequently giving rise to dis-
tinct mature B cell subclones. Alternatively, this difference
could have been generated secondary to somatic mutation
with alteration of restriction sites. Since L chain rearrange-
ment is the final event defining a mature B cell (34), sequencing
of the L chain rearrangements of FL and tDL was done to
determine the relationship of the tumor B cells. cDNA libraries
were prepared in the vectors pLIB:AZ and pLIB:ZA from
oligo(dT)-primed poly(A) + RNA derived from the FL and
tDL of case JP (26). The sources of RNA were as follows:
JP FL, single-cell suspension of lymph node andJP tDL, cell
lineJP-DLCL3. The libraries were screened with a CA probe
as described in the Materials and Methods section. Four can-
didate clones were isolated from each library. The cDNA clones
were sequenced and 5 of 8 clones were found to span the
V-J join; the sequences are shown in Fig. 2 A . The three
sequences obtained from the JP-DLCL3 cell line library were
identical and are shown as a single sequence. The similarity
in the L chain sequences demonstrate that in case JP the FL
and tDL are derived from the same mature B cell. The V
gene segments of both the FL and tDL are from the V;, I
family (35). The isolates from the FL library demonstrated
B
CONSENSUS
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JP-DIrA-3
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CONSENSUS
JP-FL_X-3
JP-FirA-4
JP-DL-A-3
CONSENSUS
JP-FL-),-3
JP-FIA-4
JP-DI,A-3
somatic mutations as has been previously described (36); the
tDL sequence showed a similar distribution of mutations
though they were more numerous. The Jx segments used in
both the FL and tDL are most similar to the human germ-
line Jx minigenes HUMJL2 or 3, whose sequences are iden-
tical (35). As illustrated in Fig. 2 B, both the FL and tDL
Jr minigenes have diverged from the germline sequence by
four identical somatic mutations; both the FL and tDL have
additional sequence changes likely the result of somatic mu-
tation. These shared mutations demonstrate a common clonal
origin. Both tumors use the same constant region though
the tDL has a single base change at position 405. When com-
pared with the consensus sequence the FL Vx gene segments
are 99 and 97% identical whereas the DL Vx gene segment
is 91% identical. This extent of alteration in the sequence
between the FL and tDL can be explained by somatic muta-
tions occurring between the time of initial diagnosis of FL
and the subsequent development of tDL (36) . A search of
V), sequences available in GenBank revealed no sequence to
be more closely related to the FL and tDL sequences than
those sequences are to each other.
Patterns ofSomatic Hypermutation in the H Chain Gene Dem-
onstrate a Single-Cell Origin of FL and tDL. If V genes ex-
pressed by FL undergo active somatic mutation during clonal
expansion, each cell within a tumor population will have a
COR1
> ATGACCTGCGTCCCTCTCCTCCTCACCCTTCTCTTTCACTGCACAGGGTCGTGGGCCCAGTCTATGTTGACGCAGCCGCCCTCAGTCTCTGCGGCCCCAGGACAGAGAGTCACCATTTCCTGCTCTGTCGGCACCTCCGCGATTGGCCAT 150
CDR2
> AAGTC-TTTTCTTGGTACCAACACGTCCCAGGTTCAGCCCCCAAAGTCCTCATTTATGACGATGATA-TCGGCCGTCAACAATTCCTGCCCGATTTTCCGGCTCCAGGTCTGCCACTTCAGCCACACTGGCCATCACAGGGCTCCAGACC 300
> __-C-A_-______-_-____-T__--_-___--________-______-_-_-__-_______-Cr-__C___-___F__--__-___-_-____-___--__--__--_-_____________-___-_______-___-___-__
> __--_C_____-____-______T______-__-___-______-__-______--__-______-A__-__-_-________-_-______-____-__-___-__-__-______________________-_______-_______
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> GGGGACGAGGGCGATTATTACTGCGCAACATGGCAGACTAATCTGAGTCCTCGATTGGTGTTCGGCGGAGGGACGAAGCTGATCGTCCTCGGTCAGCCCAAGGCTGCCCCCTCGGTCACT 420
> _-____-____-_______T_-__--___-______-_--__-___-____________________-__-__-___-_-_-___-__-_-__-___ .._______--__-__-__-____
> -__-__-___-____--_____________________-________-________-_-_____________-______-__-____-_-____-_---__-___-__-___-_-____
> ______-__-____C-________-_-___-_FT__-TC______-_T______-C_______-_____-____p,--_-C_____---__-___-___-__C_-__-__-__-__-_
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Figure 2.
￿
(A) Nucleotide sequences of the X light chain from the FL and tDL of caseJP. The leader, CDR1 and 2, joining segment (J), and constant
region (C) are indicated according to Kabat et al. (35) and are demarcated with solid horizontal lines. Individual base positions are marked by dots
() and every 10 base pairs are marked by pluses (+). The sequences designated JP-FIX were derived from the FL of case JP; the sequence designated
JP-DIA was derived from the DL of case JP. (B) Nucleotide sequence of the germline JA segment HUMJL2,3 aligned to the JA segments of the con-
sensus sequences ofJP-FLX and JP-DIA sequences. The germline sequence is from Kabat et al. (35).
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￿
plate only one ofthe six reactions yielded appropriately sized
terns of mutations can be exploited as markers of clonal evo-
￿
PCR products (ti550 by from DNA and ^450 by from
lution. IftDL arose from a single FL cell, then there should
￿
cDNA) reflecting the dominant tumor clone present (data
be common sequence alterations in the V or V1 among in-
￿
not shown) .
dependent tDL isolates. On the other hand, if transforma-
￿
Using this technique theH chain V genes were amplified,
tion arose from multipleFL cells the pattern of somatic mu-
￿
cloned, and sequenced from JP FL tumor RNA, JP-DLCL
tation would be random in independent tDL isolates.
￿
1,3,4 cell line DNA and RNA, andDNA derived from the
Ig V genes were cloned and sequenced after amplification
￿
original DLCL specimen (see Table 2) . Only the V3-L
in a PCR assay (Campbell, M ., A . Zelenetz, S. Levy, and
￿
primer amplified a product ofthe correct size . The sequences
R . Levy, manuscript submitted for publication) . Briefly, 5'
￿
are shown in Fig. 3 A ; to facilitate comparison the intron
amplimers were prepared from consensus leader sequences
￿
in the variable gene segment of clones derived from genomic
of the known V gene families (38) (VH-Ll-6) (Table 1) and
￿
DNA templates is not shown . All sequences represent V3
used in conjunction with either a Jx (37) or CI, 3' amplimer
￿
family genes on the basis of sequence comparison with data
to identify the rearrangedH chain Ig allele . For a given tem-
￿
available from GenBank, release 62 . The JN segment used in
A
￿
LmWer
n CM1tSIV1 ATCCAGTTTO=TGhGCf=TTTrCCM=T'CCTCTTTTAACACGI'CTCCAGfIDCG "(STACAGT7GCTGChGTC143000C.RGGCCTGCTCCMCC00003=CCCG%MMATTCTCCSCPGMGC=IiWATTCTTATTTAAAATA 150
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J1-1L-V1-6 ____________________________________________________________________________________________________________________________________________
ir _FL_1_3 ______________________________________________________________________________________________________________________________________________________
Jr-rc~V1_6 ______________________________________________________________________________________________________________________________________________________
ir _ a ,1_T ______________________________________________________________________________________________________________________________________________________
ar _r ,rv1_r _________-___-_____________________________________________________________________,
ir_DL_V1_1 _____________________________T_____-________________-______-,_C______C_______C_________-________________-__________________________T__________________
Jr_ay_V1_3 _____________________________T_____-_______________________-,_C______C_______C_________-___________________________________________T__________________
Jr_py_V1_6 _____________________________T_____________________________-,_C______C_______C-_________________________-________-_________________T__________________
ir-r1,._T1-1 _____________________________T_____________________________-G-C______C_____________________________________________________________T__________________
.a-rn=vr-2
￿
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JP_1u_V1-3
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nGoulvsus TATTCwTGCTCTGGGTCCGCCAGGCrccAGGm~cAOCCCTGCWTCGGTGGCCCACATAAACGAUxOGAAGTGACGAACTTTATGTGGACTCTCTGAAGGGMGRTTCAGCATCTCCAGAGACMTCTCAAGATCTCCCTCCATCTC 300
rL 0m"u1V1 CACATGTACMTGTGAGGGTCGMGATACGGCMMTATTTCTCMCGAGG AGMCAGATCCAACArTGIICAAGTGGTMTCCCATGAGCAGCAACACGTGGAMTCTGGGCCMAG=CCCTGGTCACCGTCTCCTCAGGT 414
Jr_n_v1_1 _____________________________________________________________________________________________-0_________ ..C___________---------------------------
JP-nA1_2
￿
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￿
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Jr_rL_Tr_ 5 __________________________________ ________________________________________________________________________________________-_________________
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J1-DL-V1-1
￿
-G--_-0__a_______________-0____a_________________________-0__________A____T------------------------ A____________________________________________
il-m,v1-3
￿
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JP-111rT1-2
￿
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￿
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Figure 3 .
￿
(A) Nucleotide sequences of the H chain V genes from the FL and tDL of case JP. Various regions are indicated as in Fig. 2. Differences
from an FL consensus sequence are indicated by appropriate base changes . Y indicates a C or T (see text). Individual base positions are marked by
dots (.) and every 10 base pairs are marked by pluses (+) . The sequences designated JP-PIrVH were derived from the FL in case JP ; the sequences
designated JP-DIrVH were derived from the cell lines JP-DLCL1,3, and 4; and those designated JP-PBITVH were derived from the leukemic phase
oftheDL in caseJP (see Table 1 and Materials and Methods). (B) Nucleotide sequence of the germlineJx segment HUMHJ6 aligned to the consensus
sequences ofJP-FIrVH and JP-DIrVH. The terminal 21 by of the J segment have been omitted since this is the region that is derived from thePCR
3' oligonucleotide (see Table 1) . The germline Jx sequences is from Schroeder and Wang (52) .
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or_ry-v1_1
JP-1y-V1-2
Jr_FL_V1_3
J1-ly-V1-6
Jr _ry_V1_5
-_________________________-__________________________________________-________-____________________________________________,____ .______________________
-_________________________-_____________________________T_______________________________________________-_____________________________________________
_________a______________________________________________________________________________________________-_________________________A___________________
_________________-_____________________________________T________C_____________________________________________________________________________________
_________a__________________________________________________________________________________
JP_ -"-G ______________________________________________________________________________________________________________________________________________________
a-ly-o,_T -__________________________________________________________________________________C__________________________________________________________________
Jr_m _V1_r ___________________________________________________________C_________________A___T____________________________________________________________________
.3l-DL-Vi-1 u_________ ____________________________________________________________-C______-T_____ ______________________________________________________a______
Jr-Gy_vr_3 C_________-0____________________________________________________________-C_______T_______T____________________________________________________-Q__T___
J1-ay-V1-6 C_________ ..a_____-______________________________________________-___________T______a______-_______________________________________________a______
il-P11lv1-1 C-________-0_____________________________________________________________________T_____-0_____________________ :______________________________-______
Js-113-V1-2 C_________-0_____________________________________________________________________T_____-0_____________________________________________________-0______
J1-lW-v/-3 C--________a_____________________________________________________________________T______a____________________________________________________-,______
il-1WV1-4 C--________a_____________________________________________________________________T_____-0_________________________________________________-__-, "______
J1-l1L-V1-5 C-_____________________________________________________________________________T_____-0_____________________________________________________-0______
i1-Z-vl-i C_________-0_____________________________________________________________________T_____-0_______________________-______________________________a______both the FL and tDL is most similar to the germline seg-
ment HUMJH6 (35) as shown in Fig. 3 B. Both the FL and
tDL have used an identically foreshortened form of the Jx
segment. The FL and tDL Jx sequences have diverged from
the germline by two shared sequence alterations; the FL has
an additional mutation not seen in the tDL. The common
evolution of these sequences demonstrates they arose from
the same clonal origin. The D segment was most similar to
DMI (39) though somatic mutation and lack of sequence
information aboutall D segments makes this assignment ten-
tative. Eight sequences were derived from JP FL. They are
characterized by 28 random sporadic mutations throughout
the gene. JP-FIrVH-6 andJP-FIrVH-8 each have a 1-bp dele-
tion at positions 378 and 86, respectively, which result in
nonfunctional genes secondary to termination codons in the
new reading frame. tDL sequences were derived from the
three independent JP-DLCL cell lines and six clones derived
from the original tumor specimen. The sequence from each
cell line was obtained from at least two clones. All indepen-
dent clones derived from a given cell line yielded identical
sequences except position 297 of sequenceJPRDDVH-3 which
was found to be C in a clone derived from genomic DNA
template and T in three other clones (one from a genomic
DNA template and two from cDNA templates) . This may
have arisen either as an artifact ofcloning or PCR amplification
or from ongoing somatic mutation in the JP-DLCIr3 cell
line. The independent tDL sequences are highly conserved,
sharing 17 differences from the FL consensus sequence. At
an additional three positions-78, 239, and 324-eight of
the nine tDL sequences share common differences; the ex-
ceptions may be a result ofback mutation. Furthermore, they
all share a 3-bp deletion in the region of the D-J join. The
markedly nonrandom distribution of the differences between
the FL and DL sequences strongly suggests that the tDL cell
lines were representative of the original tumor and further-
more that the tDL arose from a common origin. There are
several differences among the nine tDL sequences at positions
138, 224, 240, and 297 where there are changes affecting only
one or two sequences most likely representing ongoing so-
matic mutation after the transformation event.
Discussion
Histologic conversion of follicular to diffuse lymphoma
occurs frequently in the natural history of this disease and
is associated with poor prognosis. There are three possible
models to explain the relationship between these different
tumors within the patient. First, the tumors could be biclonal,
i.e., arising from two independent transforming events. In
a study of B cell lymphomas showing multiple histologic
forms, Siegleman et al. (40), using Southern blot analysis of
Ig gene rearrangements, found that in some instances no con-
cordant bandswere observed between distinct histologic forms
of lymphoma obtained from a single individual. Thus, they
concluded that in some cases biclonal lymphomas could de-
velop. However, FL represents a stage of B cell development
at which somatic mutation of the Ig genes is occurring at
a high rate (36, 41). Mutations can occur in restriction en-
zyme sites and alter the size of bands in a Southern analysis
(11); therefore, the absence of concordant bandsdoes not neces-
sarily indicate multiclonal origins. In the present study, the
L chain rearrangement ofcase JP and the productiveH chain
rearrangement of case MT were nonconcordant between the
FL and tDL; however, sequence analysis proved the respec-
tive variable gene rearrangement were in common (Fig. 3;
case MT, data not shown).
A second model for transformation proposes that the two
tumors are related through a common pre-B cell which had
chosen an H chain gene but had not yet chosen an L chain
gene. According to this model, the FL would arisefrom one
subclone and the tDL wo;tld arise at a later point in time
but from a different pre-B subclone. Gauwerky et al. (7, 8)
suggested this model to explain the development of a pre-B
cell acute lymphoblastic leukemia in a patient with a prior
history of FL. They found that the leukemic cells contained
two chromosomal rearrangements, t(14;18) characteristic of
FL and t(8;14) characteristic of sporadic Burkitt's lymphoma.
The contention that this tumor arose from a pre-B cell pool
harboring a t(14;18) was further supported by the finding
of terminal deoxynucleotidyltransferase (TdT) in the leukemic
blasts and the absence of sIg. A similar conclusion was reached
by de Jong et al. (9) in a report of a case of composite lym-
phomacomprised of FL and lymphoblastic lymphoma (LL).
Both components shared an identical t(14;18) and only the
LL showed the additional t(8;14) rearrangement. The FL and
LL were TdT - and TdT+, resepectively. Neither component
expressed a sIg despite the finding that both the TdT - and
TdT+ populations had concordant L chain rearrangements.
However, in the current study, 16 of 16 casesoftDL expressed
sIg demonstrating a mature B cell origin. Reactivation of
TdT expression has been observed in a murine B cell lym-
phomain which ongoing L chain rearrangements occur (42).
Therefore, an alternative explanation for the finding of sIg- ,
TdT+ tDL is that in the process of isotype switching in a
subclone of the FL B cell, activation of the c-myc oncogene
occurred giving rise to the LL. This conclusion is supported
by the finding of Gauwerky et al. (8) that the translocation
of chromosome 14 to chromosome 8 occurred in a sequence
near the C.y2 constant gene segment typical of switch re-
gions. This alternative explanation was reached by Lee et al.
(5) who reported a case of SNC-B developing in a patient
with a one-year history of untreated FL. In that case the
original FL had L chain rearrangements but was sIg - be-
cause the only Jx rearrangement was the t(14;18) transloca-
tion, the second allele was in a germline configuration. The
inability to produce a sIg because of the t(14;18) transloca-
tion has been documented in a number of cases (43) . In the
high grade tumor, subsequent translocation oft(8;14) resulted
in activation of the c-myc oncogene.
The third model for the development of tDL is the se-
quential transformation of a mature FL B cell to a higher
grade of malignancy (Fig. 4). This model is supported by
the evidence presented here demonstrating the retention of
idiotype expression in 12 of 13 cases of histologic conver-
sion. However, in four cases either antiidiotypic reagents were
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Figure 4.
￿
Schematic modelfor histolgic transformation. Malignant cells
in follicular lymphoma are characterized as mature B cells expressing sIg
and having the t(14;18) translocation. As a result ofsomatic mutation the
tumor population becomes heterogeneous with individual subclones marked
by mutation of the Ig V gene segments. The data presented show that
the tDL has a nonrandom pattern of mutation compared with the FL,
supporting the conclusion that the tDL arises from a single FL subclone.
unavailable (JP, MT, FB) or the reagent failed to bind to the
sIg of the tDL (EC). Analysis of these cases by Southern hy-
bridization revealed clonal J rearrangements supporting a
clonal origin for the FL and tDL. Since L chain rearrange-
ment is the final step in B cell maturation, a common mature
B cell origin was demonstrated in three cases (EC, FB, MT)
by identity ofL chain rearrangements. In caseJP, the L chain
rearrangements were nonidentical, suggestingeither that FL
and tDL had rearranged to different Va gene segments or
that somatic mutation had altered restriction banding pat-
tern (11). Sequence analysis of the rearranged L chains in the
FL and tDL in case JP demonstrated the genes to be very
similar. The Jx segment from both the FL and tDL diverged
from the germline Ja minigene by four common mutations
proving the common clonal origin of these tumors from a
mature B cell. This sequential model can explain both the
cases described here as well as those previously reported cases
discussed above.
The V gene sequence data allow us to take this model
one step further and to prove that transformation occurs as
the result of changes in a single FL cell (Fig. 4). In V gene
segments, the distribution of mutations is relatively random
(41, 44). Therefore, the finding ofrepetitivemutations among
independent cells in the tumor suggests that they have a
common cell of origin (45) . In this study, the FL V gene
clones for case JP were obtained from a single tumor mass.
Since there was a unique clonal immunoglobulin gene rear-
rangement basedon the Southern blot analysis (Fig. 1, A-C,
lanes 1-4) this mass represented clonal expansion of a single
progenitorcell. However, as a result of ongoing somatic mu-
tation individual cells within this tumor mass had generated
subclones marked by different patterns of mutations. Among
the 8 FL V clones examined only two positions along the
sequence showed a mutation more than once (Fig. 3). In con-
trast, 'the tDL V gene sequences from the JP tDL tumor
and cell lines were highly homologousamong themselves and
had strikingly nonrandom and repetitive differences from the
FL V gene consensus sequence. The changes seen in the tDL
included a 3-bp deletion in the D-J join raising the alternate
possibility that these tumors represent independent tumors
using a restricted V gene pool. Several lines of evidence sug-
gest this is not the explanation. First, the J segments of the
FL and tDL were both derived from an identical fore-shortened
form of the germline J6 and both had diverged from it by
two common mutations, strongly suggesting a clonal origin
of these two tumor populations. Similar analysis of the L
chain sequences also supported a common clonal origin.
Second, the V-Djoin which is composed of randomly added
nucleotides and which follows in DJjoin in B cell ontogeny,
is identical in length and differs in sequence by only 2 bp.
Furthermore, one of the changes in this sequence is also seen
in the FL clone JP-FLVH-3 suggesting this area has been
subject to somatic mutation. Third, the DJ join that con-
tains the 3-bp deletion in the tDL is otherwise identical to
the FL consensus sequence for this region. Fourth, somatic
mutation in Ig genes can include deletion of an entire codon
(46, 47). The finding that 4 of the 28 mutations observed
amongthe eight FL clones occurred in this 15-bp stretch where
only one would have been expected if the mutations were
distributed evenly suggests that the DJ join is a target for
active mutation. Finally, there is no evidence for restricted
V gene usage in FL; in more than 40 cases of FL V genes
sequenced in this laboratory, no rearranged VH gene segment
is as similar to the JP-FL V as is the JP-DL V (Bahler, D.,
M. Campbell, S. Levy, and R. Levy, manuscript in prepara-
tion). Thus, the 3-bp sequence difference in the DJ join is
most likely the result of somatic mutation and not an in-
dependently derivedjoin. The nonrandom sequence changes
among the tDL could have arisen only if tumor progression
occurred in a single FL subclone that had previously accu-
mulated a large number of sequence alterations by mutational
events. The same conclusion can be reached from the sequence
analysis of the H chain in case MT FL and tDL (data not
shown). Thus, tDL results from the transformation of a single
FL cell.
The sequence data also suggests that somatic mutation can
occur in DLCL. In addition to the common, nonrandom mu-
tations, the tDL VH clones from case JP show several ran-
domly distributed mutations which likely have occurred sub-
sequent to the transformation event. Somatic mutation appears
to occur at specific stages of B cell development. In FL, ac-
tive somatic mutation is well described (36). In contrast,
somatic mutation has not been observed in ALL, SNC-B,
and small lymphocytic lymphoma, lymphoid malignancies
representing other stages of B cell development (48-51). In
DLCL it is not known if somatic mutation is ongoing. The
three tDL cell lines developed from caseJP provide a possible
in vitro model system to study somatic mutation in DLCL.We would like to thank Micheal Campbell and Shoshana Levy for helpful discussion. In addition, we
would like to thank Michael Cleary for providing probes for the major and minor t(14;18) translocation
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flow cytometry.
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Note added in proof . Analysis of the t(14;18) chromosomal translocation by pulsed-field gel electrophoresis
confirms the clonal relationship ofFL and tDL in cases where conventional electrophoresis failed to dem-
onstrate the translocation (case JP, EC, and FB).
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